The integration of EEG signals and deep learning methods is emerging as an effective approach for brain fatigue detection, particularly utilizing Graph Neural Networks(GNNs) that excel in capturing complex electrode relationships. A significant challenge within GNNs is the construction of an effective adjacency matrix that enhances spatial information learning. Concurrently, electrode aggregation in EEG has emerged as a pivotal area of research. However, conventional partitioning methods depend on task-specific prior knowledge, limiting their generalizability across diverse tasks. To Address this issue, we propose a novel mesoscopic region division approach for EEG-based driver fatigue detection, leveraging inherent data characteristics and functional connectivity-based GNN. This method adopts a two-stage approach: initially, micro-electrodes exhibiting similar functional connectivity relationships are grouped as "mesoscopic region"; subsequently, all micro-electrodes in the same group are aggregated into virtual meso-electrodes, and the fatigue state classification is subsequently based on the functional connectivity between them. Applied to a public driver fatigue detection dataset, our approach surpasses existing state-of-the-art methods in performance. Additionally, interpretive analysis provides micro and mesoscopic insights into brain regions and neuronal connections associated with alert and fatigued states.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1109/JBHI.2024.3504847 | DOI Listing |
Wearable Technol
February 2025
Department of Biomechanical Engineering, University of Twente, Enschede, The Netherlands.
State-of-the-art controllers for active back exosuits rely on body kinematics and state machines. These controllers do not continuously target the lumbosacral compression forces or adapt to unknown external loads. The use of additional contact or load detection could make such controllers more adaptive; however, it can be impractical for daily use.
View Article and Find Full Text PDFGlob Ment Health (Camb)
February 2025
Department of Human Development, Teachers College, Columbia University, New York, USA.
We present a series of network analyses aiming to uncover the symptom constellations of depression, anxiety and somatization among 2,796 adult primary health care attendees in Goa, India, a low- and middle-income country (LMIC). Depression and anxiety are the leading neuropsychiatric causes of disability. Yet, the diagnostic boundaries and the characteristics of their dynamically intertwined symptom constellations remain obscure, particularly in non-Western settings.
View Article and Find Full Text PDFJMIR Cancer
March 2025
Division of Drug Informatics, Keio University Faculty of Pharmacy, Tokyo, Japan.
Background: Androgen receptor axis-targeting reagents (ARATs) have become key drugs for patients with castration-resistant prostate cancer (CRPC). ARATs are taken long term in outpatient settings, and effective adverse event (AE) monitoring can help prolong treatment duration for patients with CRPC. Despite the importance of monitoring, few studies have identified which AEs can be captured and assessed in community pharmacies, where pharmacists in Japan dispense medications, provide counseling, and monitor potential AEs for outpatients prescribed ARATs.
View Article and Find Full Text PDFIndian J Otolaryngol Head Neck Surg
February 2025
Department of Surgery, Command Hospital Air Force Bangalore, Bangalore, Karnataka 560007 India.
Secondary hyperparathyroidism (SHPT) is a common complication in chronic kidney disease patients, necessitating effective management to prevent adverse outcomes. This study evaluates the efficacy of surgical intervention in achieving biochemical balance in SHPT patients resistant to medical therapy. The study includes 36 patients with SHPT who underwent subtotal parathyroidectomy following failed medical management.
View Article and Find Full Text PDFCureus
February 2025
Breast and Thyroid Surgery, Kitasato University Hospital, Sagamihara, JPN.
We report two cases of adrenal insufficiency (AI) occurring during neoadjuvant treatment with pembrolizumab for breast cancer. In the first case, a 53-year-old female presented with a chief complaint of poor oral intake and fatigue. In the second case, a 46-year-old female presented with a chief complaint of fever, poor oral intake, and general fatigue and was admitted with a diagnosis of pneumonia.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!